BioAlg

Curated by Signal

AI and cloud-based disease digital modeling for drug development

Overview

AI and cloud-based disease digital modeling for drug development. The platform 'OncoUnite' uses AI technology to predict clinical trial outcomes in cancer drug development. It has features for therapy selection, data processing, digital drug designing, and more. It undergoes tumor profiling and prognostic analytics for the analysis.

Key facts

Founded: 2017
Headquarters: San Jose, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Aetion
Provides payer/provider, biopharma and medical device customers with a platform to allow them to gain insights into the clinical and financial status of a population
Health TechnologyNew York City, United States
HealthCompete
AI-powered marketing solutions for health organizations
Health TechnologyJersey City, United States
CribMD
An online platform offering teleconsultation with cardiologists, orthopedic, gynecologists & others
Health TechnologyCalifornia City, United States

About BioAlg

What does BioAlg do?

AI and cloud-based disease digital modeling for drug development.

Where is BioAlg headquartered?

BioAlg is headquartered in San Jose, United States.

When was BioAlg founded?

BioAlg was founded in 2017.

Which sector is BioAlg in?

BioAlg operates in Health Technology.

Who are BioAlg's competitors?

Companies similar to BioAlg include Aetion, HealthCompete, and CribMD.